Gan & Lee Pharmaceuticals Co Ltd (603087) — Financial Flexibility Index
Gan & Lee Pharmaceuticals Co Ltd (603087) has a Financial Flexibility Index of 0.60x as of September 2025. Free cash flow of CN¥518.16 Million (operating CF CN¥257.27 Million minus capex CN¥260.89 Million) represents 1% of total liabilities (CN¥860.37 Million). Also explore 603087 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gan & Lee Pharmaceuticals Co Ltd Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Gan & Lee Pharmaceuticals Co Ltd across 13 annual periods. Check 603087 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)
Year-by-year free cash flow to debt coverage for Gan & Lee Pharmaceuticals Co Ltd. For the full company profile including market capitalisation, see Gan & Lee Pharmaceuticals Co Ltd (603087) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.71x | CN¥1.71 Billion | CN¥784.28 Million | CN¥998.57 Million | ▲ +73.1% |
| 2024 | 0.99x | CN¥978.11 Million | CN¥537.31 Million | CN¥988.45 Million | ▼ -1.9% |
| 2023 | 1.01x | CN¥980.75 Million | CN¥427.69 Million | CN¥972.52 Million | ▼ -19.5% |
| 2022 | 1.25x | CN¥1.28 Billion | CN¥296.68 Million | CN¥1.02 Billion | ▼ -51.4% |
| 2021 | 2.58x | CN¥1.77 Billion | CN¥1.08 Billion | CN¥686.02 Million | ▼ -19.5% |
| 2020 | 3.20x | CN¥1.82 Billion | CN¥1.24 Billion | CN¥569.09 Million | ▲ +14.1% |
| 2019 | 2.81x | CN¥1.56 Billion | CN¥1.15 Billion | CN¥555.88 Million | ▲ +27.8% |
| 2018 | 2.20x | CN¥931.48 Million | CN¥418.04 Million | CN¥424.18 Million | ▼ -35.1% |
| 2017 | 3.38x | CN¥1.38 Billion | CN¥949.60 Million | CN¥408.00 Million | ▲ +14.6% |
| 2016 | 2.95x | CN¥1.03 Billion | CN¥769.63 Million | CN¥348.06 Million | ▲ +17.8% |
| 2015 | 2.51x | CN¥815.86 Million | CN¥447.42 Million | CN¥325.41 Million | ▼ -33.7% |
| 2014 | 3.78x | CN¥620.69 Million | CN¥305.22 Million | CN¥164.18 Million | ▲ +23.2% |
| 2013 | 3.07x | CN¥304.79 Million | CN¥204.73 Million | CN¥99.33 Million | — |